ÜBER DIESEN PODCAST 🔗

Aktualisierungshäufigkeit:
every 18 days
Durchschnittliche Audiolänge:
11 minutes
Englisch
Großbritannien
8 Folgen
seit 3. November 2016
episodic

NEUESTE FOLGEN 🔗

Immuno-oncology therapies have opened up the most promising frontiers in cancer treatment today. But, with drug development costs increasing, how is it possible to maintain commercial viability? Peter Winter, Editor at BioWorld, talks about challenges to commercial viability in the immuno-oncolog…

VERGANGENE FOLGEN SUCHEN

Vorhandene Folgen von Oncology Talks durchsuchen.

FRÜHERE EPISODEN

Cancer immunotherapy research continues to evolve and offers patients a transformative alternative to traditional therapies. Anette Briendl, Senior Science Editor at BioWorld, talks about the current research landscape for immunotherapies. Learn about the challenges and potential of emerging therap…
The recent buzz around CRISPR-Cas9, a genome editing tool, has revolved around its potential for treating various genetic diseases, including cancer. Jack Hopwood, Intellectual Property Consultant and Bertrand Sautier, Strategic Account Manager at Clarivate Analytics talk about how research activit…
Recently, the U.S. Patent and Trademark Office’s released a dataset that contained over 250,000 records, included patent applications and granted patents; the USPTO was interested in the insights this data could reveal to guide cancer research. Di Cross, Director of Research at Clarivate Anal…
Join Chris Willis, Manager of Discovery and Translational Sciences at Clarivate Analytics, as he talks about immuno-oncology, why it is promising for cancer patients and how it continues to evolve. Learn more about the new approved drugs on the market that treat indications of cancer and the way in…
The Cancer Moonshot Initiative is intended to accelerate the pace of cancer research. The field of cancer immunotherapy presents real promise for cancer patients – offering a less toxic treatment protocol that reduces their suffering. Amy Braden, a Solutions Specialist at Clarivate Analytics, provi…
Historically, clinicians have fought cancer with tools such as radiation, surgery and chemotherapy, which kill cancerous cells, but also damage healthy cells or nearby tissues. Immuno-oncology presents a whole new treatment paradigm; it tunes the immune system to specifically fight cancer cells wit…
Das waren alle Folgen dieses Podcasts
Rechtliche Hinweise: Der auf dieser Seite eingebettete Podcast und das Bildmaterial stammen von Clarivate Analytics – Formerly the IP&Science business of Thomson Reuters, das Eigentum seines Eigentümers ist und nicht mit Listen Notes, Inc. verbunden ist oder von diesen unterstützt wird.